Efficacy and Safety of QL1206 in the Treatment of Postmenopausal Osteoporosis With High Fracture Risk
Clinical trial NCT04128163 · UNKNOWN
Trial details
- NCT number
- NCT04128163
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-05
- Primary completion
- 2021-08-31
- Enrollment
- 440
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.